Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Opravil

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2003
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistenceM C Strain, H F Günthard, D V Havlir, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
European Journal of Immunology|February 17, 1998
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV CohortR A Morawetz, G P Rizzardi, D Glauser, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2003
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistenceM C Strain, H F Günthard, D V Havlir, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Pageof 12